Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
WHIM syndrome is an immunodeficiency disease characterized by neutropenia, hypogammaglobulinemia and extensive human papillomavirus (HPV) infection. Despite the peripheral neutropenia, bone marrow aspirates from affected individuals contain abundant mature myeloid cells, a condition termed myelokathexis. The susceptibility to HPV is disproportionate compared with other immunodeficiency conditions, suggesting that the product of the affected gene may be important in the natural control of this infection. We describe here the localization of the gene associated with WHIM syndrome to a region of roughly 12 cM on chromosome 2q21 and the identification of truncating mutations in the cytoplasmic tail domain of the gene encoding chemokine receptor 4 (CXCR4). Haplotype and mutation analyses in a pedigree transmitting myelokathexis as an apparently autosomal recessive trait support genetic heterogeneity for this aspect of the WHIM syndrome phenotype. Lymphoblastoid cell lines carrying a 19-residue truncation mutation show significantly greater calcium flux relative to control cell lines in response to the CXCR4 ligand, SDF-1, consistent with dysregulated signaling by the mutant receptor. The identification of mutations in CXCR4 in individuals with WHIM syndrome represents the first example of aberrant chemokine receptor function causing human disease and suggests that the receptor may be important in cell-mediated immunity to HPV infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alterations in GPCR signalling are implicated in the pathogenesis and treatment of neuropsychiatric55, immunological56, gastrointestinal57,58, cardiac59, renal, hormonal, infectious60 and many other disorders53,54.”
From Unexplored therapeutic opportunities in the human genome (2018) · cites this paper as [56]
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641 · cited 1×
“To date, their role in disease causation has been best established for the co-receptor function of CCR5 and CXCR4 in HIV infectio”
BackgroundParametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed · Cited by 2,877
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
Zou, Y.-R., Kottmann, A. H., Kuroda, M., Taniuchi, I., & Littman, D. R. (1998) · Nature · doi:10.1038/31269 · Cited by 2,489
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Ma, Q., Jones, D., Borghesani, P. R., Segal, R. A., Nagasawa, T., Kishimoto, T., Bronson, R. T., & Springer, T. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9448 · Cited by 1,682
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S.-I., et al. (1998) · Nature · doi:10.1038/31261 · Cited by 1,525
Multilocus linkage analysis in humans: detection of linkage and estimation of recombination.
Lathrop, M. G., Lalouel, J.-M., Julier, C., & Ott, J. (1985) · Europe PMC (PubMed Central) · Cited by 1,228
Burger, J. A., Tsukada, N., Burger, M., Zvaifler, N. J., Dell'Aquila, M., & Kipps, T. J. (2000) · Blood · doi:10.1182/blood.v96.8.2655 · Cited by 607 · cited 1×
“Moreover, CXCR4 and SDF-1 signaling has been shown to inhibit spontaneous apoptosis in human chronic lymphocytic leukemia B cell”
Background
Cited by
Cytokine-mediated regulation of CXCR4 expression in human neutrophils
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 240
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Griffith, J. W., Sokol, C. L., & Luster, A. D. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120145 · Cited by 2,059
“This syndrome is most commonly caused by mutations in CXCR4 that enhance responsiveness to CXCL12 either by impairing CXCR4 internalization and chemokine-induced desensitization or by leading to enhanced or sustained chemokine signaling (14, 15).”
BackgroundSerbina, N. V., & Pamer, E. G. (2006) · Nature Immunology · doi:10.1038/ni1309 · Cited by 1,669
“Mutations in the gene encoding CXCR4 that lead to increased responsiveness have been identified in patients with WHIM (warts, hypogammaglobulinemia, infections and myelokathexis) syndrom”
BackgroundNeutrophils, from Marrow to Microbes
Borregaard, N. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.011 · Cited by 1,573
A guide to chemokines and their receptors
Hughes, C. E., & Nibbs, R. J. B. (2018) · The FEBS Journal · doi:10.1111/febs.14466 · Cited by 1,412
Neutrophil kinetics in health and disease
Summers, C., Rankin, S. M., Condliffe, A. M., Singh, N., Peters, A. M., & Chilvers, E. R. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.05.006 · Cited by 1,242
The Chemokine System in Innate Immunity
Sokol, C. L., & Luster, A. D. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016303 · Cited by 862
“This process is defective in patients with warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome, which is caused by mutations in CXCR4 that enhance responsiveness to CXCL12 (Hernandez et al. 2003; Gulino et al. 2004).”
BackgroundInfluentialBachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
“…sites on the C terminus important for receptor desensitization and internalization (Busillo and Benovic, 2007), causing retention of mature leukocytes in the BM and possibly in other immune organs (Hernandez et al., 2003; Gulino et al., 2004; Balabanian et al., 2005b; Kawai et al., 2007).”
Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5
Allen, C. D. C., Ansel, K. M., Low, C., Lesley, R., Tamamura, H., Fujii, N., & Cyster, J. G. (2004) · Nature Immunology · doi:10.1038/ni1100 · Cited by 802
“It also suggests another immune function that is likely to be disrupted in patients with WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis) who carry C-terminal truncation mutations in CXCR4 (ref”
BackgroundCXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow
Eash, K. J., Greenbaum, A. M., Gopalan, P. K., & Link, D. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41649 · Cited by 791
Martin, C., Burdon, P. C. E., Bridger, G., Gutierrez-Ramos, J.-C., Williams, T. J., & Rankin, S. M. (2003) · Immunity · doi:10.1016/s1074-7613(03)00263-2 · Cited by 770
Kucia, M., Reca, R., Miekus, K., Wanzeck, J., Wojakowski, W., Janowska‐Wieczorek, A., Ratajczak, J., & Ratajczak, M. Z. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0342 · Cited by 759
The significance of cancer cell expression of the chemokine receptor CXCR4
Balkwill, F. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.003 · Cited by 758
Biased signalling: from simple switches to allosteric microprocessors
Smith, J. S., Lefkowitz, R. J., & Rajagopal, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.229 · Cited by 738
The phagocytes: neutrophils and monocytes
Dale, D. C., Boxer, L., & Liles, W. C. (2008) · Blood · doi:10.1182/blood-2007-12-077917 · Cited by 740
CXCR4–SDF-1 Signalling, Locomotion, Chemotaxis and Adhesion
Kucia, M., Jankowski, K., Reca, R., Wysoczynski, M., Bandura, L., Allendorf, D. J., Zhang, J., Ratajczak, J., & Ratajczak, M. Z. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000032355.66152.b8 · Cited by 698
“In contrast, however, an activating mutation of CXCR4 in patients suffering from warts, hypogammaglobulinemia, immunodeficiency and myelokathexis (WHIM) syndrome had been recently reported (Hernandez et al. 2003).”
BackgroundThe Intricate Role of CXCR4 in Cancer
(2014) · Advances in Cancer Research · doi:10.1016/b978-0-12-411638-2.00002-1 · Cited by 672
“A specific dominant germline mutation in CXCR4 gene causes WHIM syndrome (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) (Bachelerie, 2010; Hernandez et al., 2003), a immunodeficiency disorder characterized by neutropenia.”
Wilen, C. B., Tilton, J. C., & Doms, R. W. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006866 · Cited by 654
“Although the implications of CXCR4 dimerization remain unclear for HIV infection, it may explain the dominant phenotype of a carboxyterminal CXCR4 human mutation that results in WHIM syndrome, which is characterized by warts, hypogammaglobulinemia, infections, and myelokathexis (retention of neutrophils in the bone ma…”
BackgroundBusillo, J. M., & Benovic, J. L. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.11.002 · Cited by 617
“The mutations identified to date (one frameshift and three nonsense mutations) all truncate the C-terminal tail of CXCR4 (Figure 2B) eliminating 10 to 19 of the distal tail amino acids, including a number of potential phosphorylation sites [127,128].”
BackgroundNeutrophils cascading their way to inflammation
Sadik, C. D., Kim, N. D., & Luster, A. D. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.06.008 · Cited by 577
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
Li, Y. M., Pan, Y., Wei, Y., Cheng, X., Zhou, B. P., Tan, M., Zhou, X., Xia, W., Hortobagyi, G. N., Yu, D., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.027 · Cited by 537
“…transfectants of MDA-MB-435 breast cancer cells by Western blot (Figure 1D, left panel) and alsoIn addition to inducing leukocyte trafficking (Hernandez et al., 2003), CXCR4 is essential for B cell lymphopoiesis and myelo- observed in the NIH 3T3 cell and its HER2 stable transfectant (Figure…”
BackgroundPractice parameter for the diagnosis and management of primary immunodeficiency
Bonilla, F. A., Bernstein, I. L., Khan, D. A., Ballas, Z. K., Chinen, J., Frank, M. M., Kobrynski, L. J., Levinson, A. I., Mazer, B., Nelson, R. P., et al. (2005) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)61142-8 · Cited by 521
Hunter, Z. R., Xu, L., Yang, G., Zhou, Y., Liu, X., Cao, Y., Manning, R. J., Tripsas, C., Patterson, C. J., Sheehy, P., et al. (2014) · Blood · doi:10.1182/blood-2013-09-525808 · Cited by 488
“Eight of 30 (27%) patients harbored 1 of 5 somatic variants in CXCR4, each of which were identical or functionally similar to mutations associated with WHIM syndrome (Figure 1).(20,21) WHIM syndrome is a rare, autosomal dominant genetic disorder that is caused by frameshift or nonsense mutations in the carboxyl-termin…”
BackgroundNeutrophil mobilization and clearance in the bone marrow
Furze, R. C., & Rankin, S. M. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02950.x · Cited by 460
The pleiotropic effects of the SDF-1–CXCR4 axis in organogenesis, regeneration and tumorigenesis
Ratajczak, M. Z., Zuba-Surma, E., Kucia, M., Reca, R., Wojakowski, W., & Ratajczak, J. (2006) · Leukemia · doi:10.1038/sj.leu.2404357 · Cited by 424
Unexplored therapeutic opportunities in the human genome
Oprea, T. I., Bologa, C. G., Brunak, S., Campbell, A., Gan, G. N., Gaulton, A., Gomez, S. M., Guha, R., Hersey, A., Holmes, J., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.14 · Cited by 378
Severe congenital neutropenias
Skokowa, J., Dale, D. C., Touw, I. P., Zeidler, C., & Welte, K. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.32 · Cited by 383
G-CSF and GM-CSF in Neutropenia
Mehta, H. M., Malandra, M., & Corey, S. J. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500861 · Cited by 363
“Mutations in CXCR4 result in the syndrome (41).”
BackgroundHu, Z., & Ma, D. (2018) · Cancer Medicine · doi:10.1002/cam4.1501 · Cited by 338
“Obvious evidence of genetic factors contributing to cervical carcinogenesis can be proved by warts, hypogammaglobulinemia, immunodeficiency, and myelokathexis syndrome (WHIM) and hereditary nonpolyposis colorectal cancer (Lynch) syndrome, two autosomal dominant genetic disorder characterized by extensive HPV infection…”
BackgroundEash, K. J., Means, J. M., White, D. W., & Link, D. C. (2009) · Blood · doi:10.1182/blood-2008-09-177287 · Cited by 313
Balabanian, K. (2005) · Blood · doi:10.1182/blood-2004-06-2289 · Cited by 322
CCL2 (monocyte chemoattractant protein-1) and cancer
Conti, I., & Rollins, B. J. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.009 · Cited by 314
“The only example that even comes close is the increased incidence of cervical carcinoma in women with WHIM syndrome[2].”
BackgroundErratum: Unexplored therapeutic opportunities in the human genome
Oprea, T. I., Bologa, C. G., Brunak, S., Campbell, A., Gan, G. N., Gaulton, A., Gomez, S. M., Guha, R., Hersey, A., Holmes, J., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.52 · Cited by 311
Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses
Orth, G. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.07.008 · Cited by 249
Furusato, B., Mohamed, A., Uhlén, M., & Rhim, J. S. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02548.x · Cited by 290
Molecular Pathways: Targeting the CXCR4–CXCL12 Axis—Untapped Potential in the Tumor Microenvironment
Scala, S. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0914 · Cited by 290
“WHIM syndrome is associated with germline-dominant mutations in the C-terminus of CXCR4, which result in a truncation of the receptor (23).”
BackgroundHomeostatic Regulation of Blood Neutrophil Counts
von Vietinghoff, S., & Ley, K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5183 · Cited by 292
Busillo, J. M., Armando, S., Sengupta, R., Meucci, O., Bouvier, M., & Benovic, J. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091173 · Cited by 281
The human model: a genetic dissection of immunity to infection in natural conditions
Casanova, J.-L., & Abel, L. (2004) · Nature Reviews Immunology · doi:10.1038/nri1264 · Cited by 277
Small Molecule Inhibitors of CXCR4
Debnath, B., Xu, S., Grande, F., Garofalo, A., & Neamati, N. (2013) · Theranostics · doi:10.7150/thno.5376 · Cited by 273
“Inherited mutations in the gene encoding CXCR4 have been also reported to correlate with the disorder [45, 46].”
BackgroundGenome-wide identification of genes likely to be involved in human genetic disease
Lopez-Bigas, N. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh605 · Cited by 261
“Two new disease genes have been described in the recent literature: CXCR4 as the causative gene of WHIM syndrome (26) and the GARS gene involved in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V (CMT2D/dSMA-V) (27).”
BackgroundCXCR4 signaling in health and disease
Pozzobon, T., Goldoni, G., Viola, A., & Molon, B. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.06.006 · Cited by 256
Devi, S., Wang, Y., Chew, W. K., Lima, R., A-González, N., Mattar, C. N. Z., Chong, S. Z., Schlitzer, A., Bakocevic, N., Chew, S., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130056 · Cited by 243
“, 2011) with gain-of-function mutations in CXCR4 that confers the warts, hypogammaglobulinemia, immunodeficiency, and myelokathexis (WHIM) syndrome (Hernandez et al., 2003).”
BackgroundCottler-Fox, M. H., Lapidot, T., Petit, I., Kollet, O., DiPersio, J. F., Link, D., & Devine, S. (2003) · Hematology · doi:10.1182/asheducation-2003.1.419 · Cited by 240
The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies
Daniel, S. K., Seo, Y. D., & Pillarisetty, V. G. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.007 · Cited by 239
Durandy, A., Kracker, S., & Fischer, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3466 · Cited by 220
SDF-1α as a therapeutic stem cell homing factor in myocardial infarction
Ghadge, S. K., Mühlstedt, S., Özcelik, C., & Bader, M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.011 · Cited by 218
WHIM syndrome: congenital immune deficiency disease
Kawai, T., & Malech, H. L. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32831ac557 · Cited by 218
“active immunizations indicating that the defect in humeral immunity is not complete [7,24, 34].”
BackgroundInfluentialCurrent mechanistic scenarios in hematopoietic stem/progenitor cell mobilization
Papayannopoulou, T. (2004) · Blood · doi:10.1182/blood-2003-05-1595 · Cited by 215
Molecular Mechanisms of HIV Entry
Wilen, C. B., Tilton, J. C., & Doms, R. W. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-0980-9_10 · Cited by 213
Primordial germ cell migration in the chick and mouse embryo: the role of the chemokine SDF-1/CXCL12
Stebler, J., Spieler, D., Slanchev, K., Molyneaux, K. A., Richter, U., Cojocaru, V., Tarabykin, V., Wylie, C., Kessel, M., & Raz, E. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.05.009 · Cited by 211
“, 2003), as well as in infectious and inflammatory processes (Abi-Younes et al., 2000; Buckley et al., 2000; Feng et al., 1996; Gonzalo et al., 2000; Hernandez et al., 2003).”
BackgroundPawig, L., Klasen, C., Weber, C., Bernhagen, J., & Noels, H. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00429 · Cited by 209
“WHIM syndrome is characterized by severe neutropenia despite having abundant mature myeloid cells in the bone marrow, which is termed myelokathexis (232).”
BackgroundCongenital neutropenia: diagnosis, molecular bases and patient management
Donadieu, J., Fenneteau, O., Beaupain, B., Mahlaoui, N., & Chantelot, C. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-26 · Cited by 211
“Subsequent identification of the role of a chemokine receptor gene (CXCR4)[100] led to a better understanding of this disease and showed that this syndrome corresponds to the same entity, although warts may not initially be present.”
BackgroundInfluentialEntry inhibitors in the treatment of HIV-1 infection
Tilton, J. C., & Doms, R. W. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.07.022 · Cited by 208
Roccaro, A. M., Sacco, A., Jimenez, C., Maiso, P., Moschetta, M., Mishima, Y., Aljawai, Y., Sahin, I., Kuhne, M., Cardarelli, P., et al. (2014) · Blood · doi:10.1182/blood-2014-03-564583 · Cited by 207
Patel, A. A., Ginhoux, F., & Yona, S. (2021) · Immunology · doi:10.1111/imm.13320 · Cited by 199
Regulation of neutrophil homeostasis
Christopher, M. J., & Link, D. C. (2007) · Current Opinion in Hematology · doi:10.1097/00062752-200701000-00003 · Cited by 198
Warts and all: Human papillomavirus in primary immunodeficiencies
Leiding, J. W., & Holland, S. M. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.049 · Cited by 192
Chromothriptic Cure of WHIM Syndrome
McDermott, D. H., Gao, J.-L., Liu, Q., Siwicki, M., Martens, C., Jacobs, P., Velez, D., Yim, E., Bryke, C. R., Hsu, N., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.014 · Cited by 190
“WHIM syndrome is an autosomal dominant combined primary immunodeficiency disease caused by mutations in the chemokine receptor CXCR4 (Hernandez et al., 2003).”
BackgroundMethodInfluentialGulino, A. V., Moratto, D., Sozzani, S., Cavadini, P., Otero, K., Tassone, L., Imberti, L., Pirovano, S., Notarangelo, L. D., Soresina, R., et al. (2004) · Blood · doi:10.1182/blood-2003-10-3532 · Cited by 189
Pathological roles of the homeostatic chemokine CXCL12
Janssens, R., Struyf, S., & Proost, P. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.10.004 · Cited by 185
CXCR 4, the master regulator of neutrophil trafficking in homeostasis and disease
De Filippo, K., & Rankin, S. M. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12949 · Cited by 184
“WHIM-associated mutations of CXCR4 result in the production of a C-terminal truncated receptor that displays impaired internalisation and enhanced signalling, resulting in abnormal neutrophil retention in the bone marrow (myelokathexis) and a consequent chronic blood neutropenia (Figure 1).(15,16) Therefore, despite h…”
BackgroundMozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration
De Clercq, E. (2019) · Antiviral Chemistry and Chemotherapy · doi:10.1177/2040206619829382 · Cited by 174
“It was first described by Zuelzer et al.77 and Krill et al.78 and identified as an immunological disorder by Wetzler et al.79 That the myelokathexis was part of an autosomal dominant disorder, WHIM syndrome, was characterized by Gorlin et al.76 The cause of almost all cases of WHIM syndrome is the inheritance of carbo…”
BackgroundMobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4
Rettig, M. P., Ansstas, G., & DiPersio, J. F. (2012) · Leukemia · doi:10.1038/leu.2011.197 · Cited by 176
Lagane, B., Chow, K. Y. C., Balabanian, K., Levoye, A., Harriague, J., Planchenault, T., Baleux, F., Gunera-Saad, N., Arenzana-Seisdedos, F., & Bachelerie, F. (2008) · Blood · doi:10.1182/blood-2007-07-102103 · Cited by 171
The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases
García-Cuesta, E. M., Santiago, C. A., Vallejo-Díaz, J., Juarranz, Y., Rodríguez-Frade, J. M., & Mellado, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00585 · Cited by 170
“These patients can suffer neutropenia, B cell lymphopenia, hypogammaglobulinemia which is related to recurrent infections and BM myelokathexis characterized by myeloid hyperplasia and increased numbers of mature, senescence neutrophils in the bone marrow (75).”
BackgroundCXC chemokine ligand 12 (CXCL12) and its receptor CXCR4
Nagasawa, T. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1123-8 · Cited by 169
“On the other hand, the first example of aberrant chemokine receptor function causing human disease is the identification of mutations in CXCR4 in individuals with WHIM syndrome [53].”
BackgroundCXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy
Mousavi, A. (2020) · Immunology Letters · doi:10.1016/j.imlet.2019.11.007 · Cited by 165
Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies
Treon, S. P., Xu, L., Guerrera, M. L., Jimenez, C., Hunter, Z. R., Liu, X., Demos, M., Gustine, J., Chan, G., Munshi, M., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02314 · Cited by 165
“Germline mutations in the C-terminal domain of CXCR4 are present in patients with WHIM (autosomal dominant warts, hypogammaglobulinemia, infection, and myelokathexis) syndrome.(40) In patients with WHIM syndrome, activation of CXCR4 by its ligand CXCL12 induces extended chemotactic signaling and neutrophil sequestrati…”
BackgroundThe bone marrow: a site of neutrophil clearance
Rankin, S. M. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0210112 · Cited by 165
“When cells are stimulated with CXCL12, CXCR4 is not internalized efficiently as a result of impaired binding of -arrestin and GRK6, which are required for internalization and trafficking to the lysosomes [105–107].”
BackgroundConcepts of GPCR‐controlled navigation in the immune system
Lämmermann, T., & Kastenmüller, W. (2019) · Immunological Reviews · doi:10.1111/imr.12752 · Cited by 161
Seidel, M. G. (2014) · Blood · doi:10.1182/blood-2014-06-583260 · Cited by 158
Involvement of CXCR4 in Normal and Abnormal Development
Kawaguchi, N., Zhang, T., & Nakanishi, T. (2019) · Cells · doi:10.3390/cells8020185 · Cited by 162
“WHIM syndrome is a rare inherited primary immunodeficiency disorder caused by autosomal dominant gain-of-function mutations in the CXCR4 gene [99-101].”
BackgroundRezaei, N., Hedayat, M., Aghamohammadi, A., & Nichols, K. E. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.02.047 · Cited by 158
“WHIM syndrome is inherited in an autosomal dominant fashion and is caused primarily by heterozygous gain-offunction mutations in the gene encoding the chemokine receptor CXCR4.(98) CXCR4 is a member of the G protein–coupled receptor (GPCR) superfamily, which selectively binds the CXC chemokine stromal cell–derived fac…”
BackgroundLaffort, C., Deist, F. L., Favre, M., Caillat-Zucman, S., Radford-Weiss, I., Fraitag, S., Blanche, S., Cavazzana-Calvo, M., Basile, G. D. S., de Villartay, J. P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16457-x · Cited by 145
Live imaging of neutrophil motility in a zebrafish model of WHIM syndrome
Walters, K., Green, J. M., Surfus, J. C., Yoo, S. K., & Huttenlocher, A. (2010) · Blood · doi:10.1182/blood-2010-03-276972 · Cited by 168
Grundler, R., Brault, L., Gasser, C., Bullock, A. N., Dechow, T. N., Woetzel, S., Pogačić, V., Villa, A., Ehret, S., Berridge, G., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20082074 · Cited by 162
“Natural mutants in patients with WHIM syndrome, as well as artificial truncation and alanine scanning mutagenesis, have suggested multiple regions in the CXCR4 C-terminal domain as potential phosphoacceptor sites (Hernandez et al., 2003).”
BackgroundLazarczyk, M., Cassonnet, P., Pons, C., Jacob, Y., & Favre, M. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00033-08 · Cited by 131
“tions in the CXCR4 chemokine receptor gene (82), leading to”
BackgroundThe CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome
McDermott, D. H., Liu, Q., Ulrick, J., Kwatemaa, N., Anaya‐O’Brien, S., Penzak, S. R., Filho, J. O., Priel, D. A. L., Kelly, C., Garofalo, M. E., et al. (2011) · Blood · doi:10.1182/blood-2011-07-368084 · Cited by 151
“This hypothesis draws its strength from multiple independent lines of evidence, including: (1) CXCL12-CXCR4 signaling is known to normally mediate neutrophil retention in the BM of mice9,21,22; (2) CXCR4 is the disease gene in WHIM syndrome5; (3) the CXCR4R334X variant found in our WHIM patients exhibits increased ago…”
MethodRegulation of Circulating Neutrophil Numbers under Homeostasis and in Disease
Strydom, N., & Rankin, S. M. (2013) · Journal of Innate Immunity · doi:10.1159/000350282 · Cited by 162
McDermott, D. H., Liu, Q., Velez, D. S., Lopez, L., Anaya‐O’Brien, S., Ulrick, J., Kwatemaa, N., Starling, J., Fleisher, T. A., Priel, D. A. L., et al. (2014) · Blood · doi:10.1182/blood-2013-09-527226 · Cited by 150
“WHIM syndrome is a rare primary immunodeficiency disorder whose name is an acronym of its main clinical features: warts, hypogammaglobulinemia, infections, and myelokathexis.1-3 Although myelokathexis refers specifically to bone marrow retention of neutrophils resulting in severe neutropenia, most patients are actuall…”
BackgroundChong, S. Z., Evrard, M., Devi, S., Chen, J., Lim, J. Y., See, P., Zhang, Y., Adrover, J. M., Lee, B., Tan, L., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20160800 · Cited by 142
“, 2014) reverses the observed monocytopenia present in patients with WHIM syndrome (Warts, hypogamma-globulinemia, infections, and myelokathexis; Hernandez et al., 2003; Gulino et al., 2004).”
BackgroundCXCR4 and a cell-extrinsic mechanism control immature B lymphocyte egress from bone marrow
Beck, T. C., Gomes, A. C., Cyster, J. G., & Pereira, J. P. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20140457 · Cited by 164
“…that B cell–intrinsic 41 and VCAM-1 expressed on sinusoidal endothelial cells may antagonize reverse CXCR4 (R334X mutation that causes the WHIM syndrome in humans [Hernandez et al., 2003]) was sufficient to prevent immature B lymphocyte egress from BM parenchyma into sinusoids and into PB (Fig.”
Chaperoning G Protein-Coupled Receptors: From Cell Biology to Therapeutics
Tao, Y., & Conn, P. M. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1121 · Cited by 156
Balabanian, K., Brotin, É., Biajoux, V., Bouchet‐Delbos, L., Lainey, É., Fenneteau, O., Bonnet, D., Fiette, L., Émilie, D., & Bachelerie, F. (2012) · Blood · doi:10.1182/blood-2012-01-403378 · Cited by 142
Auer, P. L., Teumer, A., Schick, U. M., O'Shaughnessy, A., Lo, K. S., Chami, N., Carlson, C., de Denus, S., Dubé, M., Haessler, J., et al. (2014) · Nature Genetics · doi:10.1038/ng.2962 · Cited by 159
Chua, A. W. L., Hay, H. S., Rajendran, P., Shanmugam, M. K., Li, F., Bist, P., Koay, E. S.-C., Lim, L. H. K., Kumar, A. P., & Sethi, G. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.045 · Cited by 140
Spiegel, A., Kollet, Ó., Peled, A., Abel, L., Nagler, A., Bielorai, B., Rechavi, G., Vormoor, J. H., & Lapidot, T. (2003) · Blood · doi:10.1182/blood-2003-06-1891 · Cited by 139
Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling
Balabanian, K., Levoye, A., Klemm, L., Lagane, B., Hermine, O., Harriague, J., Baleux, F., Arenzana‐Seisdedos, F., & Bachelerie, F. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33187 · Cited by 137
“Many cases of WHIM syndrome have been linked to inherited heterozygous autosomal dominant mutations in the gene encoding CXCR4, a GPCR with a unique natural ligand, the chemokine stromal cell– derived factor 1/CXCL12 (SDF-1/CXCL12) (3).”
BackgroundSung, B., Jhurani, S., Ahn, K. S., Mastuo, Y., Yi, T., Guha, S., Liu, M., & Aggarwal, B. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2155 · Cited by 140
“CXCR4 has been linked with leukocyte trafficking ( 13 ), B-cell lymphopoiesis and myelopoiesis (14), neuronal cell migration (15), and HIV invasion of host cells (16).”
BackgroundSharma, M., Afrin, F., Satija, N. K., Tripathi, R. P., & Gangenahalli, G. U. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0263 · Cited by 142
“…hematopoietic reconstitution as well that need to be explored further, which will likely improve the clinical applications and success of HSCT. WHIM syndrome is a congenital immune deficiency characterized by warts, hypogammaglobulinemia, recurrent bacterial infection, and myelokathexis [104–107].”
Beaussant, S. C., Fenneteau, O., Plouvier, E., Rohrlich, P., Daltroff, G., Plantier, I., Dupuy, A., Kérob, D., Beaupain, B., Bordigoni, P., et al. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-71 · Cited by 134
“Most patients present heterozygous autosomal dominant mutations of the gene encoding for CXCR4, the receptor of the CXCL12 chemokine (or Stromal cell Derived Factor-1) [4], which notably regulates hematopoiesis and peripheral trafficking of neutrophil and lymphocyte subsets.”
BackgroundAdvances in understanding the genetic basis for bone-marrow failure
Lieberman, L., & Dror, Y. (2006) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000192520.48411.fa · Cited by 137
CXCR4 antagonist AMD3100 (plerixafor): From an impurity to a therapeutic agent
Wang, J., Tannous, B. A., Poznansky, M. C., & Chen, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105010 · Cited by 138
Structure-based ligand discovery for the protein–protein interface of chemokine receptor CXCR4
Mysinger, M. M., Weiss, D. R., Ziarek, J. J., Gravel, S., Doak, A. K., Karpiak, J. D., Heveker, N., Shoichet, B. K., & Volkman, B. F. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120431109 · Cited by 132
“The receptor is involved in disease states such as myocardial infarction/reperfusion injury (11), myelokathexis (12), human immunodeficiency virus (HIV) infection (13), and the growth and development of more than 20 different types of cancer (14).”
BackgroundShanmugam, M. K., Manu, K. A., Ong, T. H., Ramachandran, L., Surana, R., Bist, P., Lim, L. H. K., Kumar, A. P., Hui, K. M., & Sethi, G. (2011) · International Journal of Cancer · doi:10.1002/ijc.26120 · Cited by 134
Wang, G., Hu, W., Chen, H., Shou, X., Ye, T., & Xu, Y. (2019) · Cancers · doi:10.3390/cancers11101560 · Cited by 132
“CXCR4 is one of the best-characterized chemokine receptors mediating leukocyte trafficking [40].”
BackgroundHuman primary immunodeficiency diseases: a perspective
Fischer, A. (2003) · Nature Immunology · doi:10.1038/ni1023 · Cited by 138
Neutrophils in host defense: new insights from zebrafish
Harvie, E. A., & Huttenlocher, A. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr1114-524r · Cited by 148
“Expression of the human WHIM mutations [68] in zebrafish neutrophils impairs Cxcr4b internalization and leads to retention of neutrophils in the CHT.”
BackgroundGenomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia
Poulain, S., Roumier, C., Caillault, A., Figeac, M., Herbaux, C., Marot, G., Doye, E., Bertrand, E., Geffroy, S., Leprêtre, F., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0646 · Cited by 140
Metadata
- Authors
- Hernandez, P. A., Gorlin, R. J., Lukens, J. N., Taniuchi, S., Bohinjec, J., Francois, F., Klotman, M. E., & Diaz, G. A.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- University of Minnesota (US)
- Vanderbilt University (US)
- Kansai Medical University (JP)
- Ljubljana University Medical Centre (SI)
- Venue
- Nature Genetics
- Published
- 2003-04-14
- Volume
- 34
- Issue
- 1
- Pages
- 70-74
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2167070743
- Cited by
- 722
- References
- 30
- Citations by year
- 2026: 11 · 2025: 20 · 2024: 40 · 2023: 26 · 2022: 21 · 2021: 25 · 2020: 33 · 2019: 38 · 2018: 39 · 2017: 37 · 2016: 34 · 2015: 37 · 2014: 48 · 2013: 32 · 2012: 35
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- WHIM syndrome, CXCR4, myelokathexis, combined immunodeficiency, neutropenia, hypogammaglobulinemia, HPV infection, calcium flux, autosomal recessive inheritance, genetic heterogeneity, cell-mediated immunity
- MeSH terms
- Agammaglobulinemia, B-Lymphocytes, Base Sequence, Chromosomes, Human, Pair 2, DNA, DNA Mutational Analysis, Female, Humans, Immunologic Deficiency Syndromes, Genetic Linkage, Male, Models, Molecular, Molecular Sequence Data, Mutation, Neutropenia, Pedigree, Warts, Receptors, CXCR4, Calcium Signaling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.